RASSF1A和WIF-1基因甲基化程度与直肠癌患者新辅助放化疗疗效的关系

doi:10.3969/j.issn.1671-7171.2022.07.004

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1147 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨血清Ras相关区域家族1A基因(RASSF1A)和Wnt抑制因子-1(WIF-1)基因甲基化程度与直肠癌患者新辅助放化疗(nCRT)疗效的关系。【方法】选取本院收治的109例直肠癌患者为研究对象,均给予nCRT治疗。分析患者治疗效果,根据肿瘤消退程度分级(TRG)标准分为观察组(nCRT敏感,n=73)和对照组(nCRT不敏感,n=36)。收集两组患者年龄、性别、肿瘤距离肛门位置、分化类型、临床分期、淋巴结转移及合并疾病等临床资料,对比两组血清RASSF1A和WIF-1基因甲基化阳性表达率,分析RASSF1A和WIF-1基因甲基化程度与直肠癌患者nCRT疗效的相关性。【结果】两组年龄、性别、肿瘤距离肛门位置、分化类型、临床分期、淋巴结转移、合并疾病构成比及血压、血脂水平相比较,差异无统计学意义(P>0.05)。观察组血清RASSF1A基因阳性率为16.44%(12/73)、WIF-1基因甲基化阳性率为13.70%(10/73),均低于对照组的41.67%(15/36)和33.33%(12/36),且差异均有统计学意义(P<0.05)。经Spearman检验,血清RASSF1A和WIF-1基因甲基化程度与疗效呈负相关(P<0.01)。【结论】RASSF1A和WIF-1基因甲基化程度与直肠癌患者nCRT疗效关系密切,RASSF1A和WIF-1基因甲基化阳性率越高,患者nCRT疗效越低。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张荣枝
	荆威

关键词 ：直肠肿瘤/病理学, 肿瘤抑制蛋白质类/遗传学, 甲基化, 化放疗

Abstract：【Objective】 To investigate the relationship between the methylation of Ras related region family 1A gene (RASSF1A) and Wnt inhibitor factor-1(WIF-1) gene in serum and the efficacy of neoadjuvant radiotherapy and chemotherapy (nCRT) in patients with rectal cancer. 【Methods】A total of 109 patients with rectal cancer in our hospital were selected as the study subjects,and all of them were treated with nCRT. The treatment effect was analyzed. The patients were divided into observation group (nCRT sensitive,n=73) and control group (nCRT insensitive,n=36) according to the tumor regression grade (TRG) standard; The age,sex,tumor distance from anal position,differentiation type,clinical stage,lymph node metastasis and associated diseases of the two groups were collected,and the positive expression rates of RASSF1A and WIF-1 gene methylation in the two groups were compared,the correlation between the methylation degree of RASSF1A and WIF-1 genes and the efficacy of nCRT in rectal cancer patients were analyzed. 【Results】 There was no significant difference between the two groups in age,sex,distance from the tumor to the anal position,differentiation type,clinical stage,lymph node metastasis,combined disease constituent ratio,blood pressure and blood lipid level (P>0.05). The positive rates of RASSF1A gene and WIF-1 gene methylation in serum of the observation group were 16.44% (12/73) and 13.70% (10/73),both lower than 41.67% (15/36) and 33.33% (12/36) of the control group (P<0.05). Spearman test showed that the methylation degree of RASSF1A and WIF-1 genes in serum was negatively correlated with the curative effect (P<0.01). 【Conclusion】The degree of methylation of RASSF1A and WIF-1 genes is closely related to the efficacy of NCRT in patients with rectal cancer. The higher the positive rate of methylation of RASSF1A and WIF-1 genes,the lower the efficacy of NCRT in patients with rectal cancer.

Key words： Rectal Neoplasms/PA Tumor Suppressor Proteins/GE Methylation Chemoradiotherapy

收稿日期: 2022-01-10

中图分类号:

R735.37

基金资助:陕西省中医药管理局科研项目(2019-GJ-JC017)

通讯作者: **E-mail:583633815@qq.com

引用本文:

张荣枝, 荆威. RASSF1A和WIF-1基因甲基化程度与直肠癌患者新辅助放化疗疗效的关系[J]. 医学临床研究, 2022, 39(7): 973-976.
ZHANG Rong-zhi, JING Wei. Relationship between the Methylation Degree of RASSF1A and WIF-1 Genes and the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy in Rectal Cancer Patients. JOURNAL OF CLINICAL RESEARCH, 2022, 39(7): 973-976.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.07.004 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I7/973

[1] GUO Y,WANG Q.Preoperative prediction of perineural invasion with multi-modality radiomics in rectal cancer[J].Sci Rep,2021,11(1):9429.
[2] RÖDEL C,HOFHEINZ R,FOKAS E.Rectal cancer: Neoadjuvant chemoradiotherapy[J].Best Pract Res Clin Gastroenterol,2016,30(4):629-639.
[3] MARTINEZ-USEROS J,MORENO I.The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer[J].BMC Cancer,2018,18(1):144.
[4] SONG M,GENG J,WANG L,et al. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer[J].Radiat Oncol,2019,14(1):138.
[5] DABRAL S,MUECKE C,VALASARAJAN C,et al. A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension[J].Nat Commun,2019,10(1):2130.
[6] MALPELI G,INNAMORATI G,DECIMO I,et al. Methylation dynamics of RASSF1A and its impact on cancer[J]. Cancers (Basel),2019,11(7):959.
[7] 银广悦,刘创建,周志伟,等. SFRP1及 WiF-1基因启动子甲基化检测在结直肠癌早期筛查中的价值[J].山东医药,2016,56(41):54-56.
[8] 中华人民共和国国家卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会. 结直肠癌诊疗规范(2015年版)[J].肿瘤综合治疗电子杂志,2017,3(1):19.
[9] 赵权权,傅传刚,于恩达,等. 直肠癌原发肿瘤消退分级与淋巴结消退分级关系的研究[J].中华胃肠外科杂志,2017,20(9):1050-1054.
[10] WANG B,HUANG Y.Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis[J].J Cancer Res Clin Oncol,2020,146(8):2161-2171.
[11] 郑岷江,罗斌,王康. 新辅助放化疗对直肠癌患者三年生存率和生存质量的影响分析[J].实用医院临床杂志,2021,18(2):152-155.
[12] 胡斐,陈丽,毕明瑜,等. RASSF1A基因及其在结直肠癌中的研究进展[J].生命科学,2020,32(2):143-148.
[13] 何樱,黄维甄,欧阳考滨,等. 结直肠癌患者粪便p16INK4a、MGMT、RASSF1A基因甲基化状态观察[J].山东医药,2017,57(31):9-12.
[14] 周正阳. 血清RASSF1A和WIF-1甲基化水平可用于评估晚期乳腺癌新辅助化疗TAC方案[J].基因组学与应用生物学,2018,37(4):1739-1744.